TTUHSC researcher receives $1.76 million grant to investigate new pancreatic cancer treatment

With a survival rate in the single digits, pancreatic ductal adenocarcinoma (PDAC) is highly lethal. In fact, by the time PDAC is clinically diagnosed, it is already considered incurable via surgery or other means in up to 90% of patients.

Cresco Labs Q1 Revenue Falls 5%

Cresco Labs Reports Continued Trend of Financial Improvement with First Quarter 2024 Financial Results Over 10x year-over-year increase in operating cash flow CHICAGO–(BUSINESS WIRE)– Cresco

May 15, 2024

RPGRIP1L gene expression levels can be a potential prognostic marker for invasive breast cancer

A protein called retinitis pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) performs various functions that are important for development and for health throughout life, and

May 15, 2024

An Arm and a Leg: How a surprise bill can hitch a ride to the hospital

How did three siblings who took identical ambulance rides (from the same car wreck to the same hospital) end up with three wildly different bills?

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.